Wed, June 8, 2022

Li Watsek Maintained (VINC) at Buy with Decreased Target to $8 on, Jun 8th, 2022

Li Watsek of Cantor Fitzgerald, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $22 to $8 on, Jun 8th, 2022.

Li has made no other calls on VINC in the last 4 months.



There are 4 other peers that have a rating on VINC. Out of the 4 peers that are also analyzing VINC, 0 agree with Li's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Li


  • Jonathan Chang of "SVB Leerink" Maintained at Buy with Decreased Target to $6 on, Tuesday, June 7th, 2022
  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, June 7th, 2022
  • Matthew Barcus of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $4 on, Tuesday, June 7th, 2022
  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $28 on, Wednesday, March 30th, 2022